{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T06:07:11Z","timestamp":1784268431686,"version":"3.55.0"},"reference-count":40,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Program for Young Talents of Basic Research in Universities of Heilongjiang Province","award":["YQJH2025225"],"award-info":[{"award-number":["YQJH2025225"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceutics"],"abstract":"<jats:p>Background: The highly heterogeneous and dynamically evolving tumor microenvironment leads to the development of drug resistance and recurrence in traditional therapies. Although immunotherapy demonstrates unique advantages, its clinical utility remains constrained by the suboptimal immunogenicity and the limited effect of monotherapy. Herein, a hybrid drug delivery system based on a spatiotemporal hierarchical controlled-release strategy was proposed to achieve dual immunotherapy with immune checkpoint blockade (ICB) and immunogenic cell death (ICD) to promote synergistic anti-tumor therapy. Methods: A liposome\u2013micelle hybrid drug delivery system (RUT-RPP-LP) was constructed using a lipid bilayer composed of dioleoyl phosphatidylethanolamine\/hemisuccinyl cholesterol to encapsulate rutin (RUT) and to form an inner cavity-encapsulated resveratrol micelle (RPP). RUT-RPP-LP was characterized, and its pH sensitivity and release behavior were investigated. Subsequently, a colon cancer tumor-bearing mouse model was constructed to evaluate the in vivo targeted anti-tumor effect and biological safety. On this basis, the combined mechanism of ICB and ICD was preliminarily explored. Results: RUT-RPP-LP possessed excellent formulation characteristics, stability, and biocompatibility, achieving graded controlled release of drugs via responding to the TME and lysosomal acidity, respectively. Obviously, RUT-RPP-LP could specifically target the tumor site, induce the occurrence of ICD, and simultaneously block the PD-1\/PD-L1 immune checkpoint signaling pathway, thereby enhancing the function of T cells and inducing apoptosis of tumor cells. Conclusions: The RUT-RPP-LP based on the hierarchical controlled-release strategy exerted a spatiotemporally coordinated enhancement of anti-tumor immunity, and may provide a novel combinatorial approach to overcome the low response of immunotherapy in solid tumors.<\/jats:p>","DOI":"10.3390\/pharmaceutics18070872","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T05:32:17Z","timestamp":1784266337000},"page":"872","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hybrid Drug Delivery System Designed from Spatiotemporal Hierarchical Controlled-Release Strategy Co-Delivering Rutin and Resveratrol for Coordinated Anti-Tumor Immunotherapy"],"prefix":"10.3390","volume":"18","author":[{"given":"Weinan","family":"Li","sequence":"first","affiliation":[{"name":"School of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin 150040, China"},{"name":"Key Laboratory of Basic and Application Research of Beiyao, Heilongjiang University of Chinese Medicine, Ministry of Education, Harbin 150040, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-9657-7107","authenticated-orcid":false,"given":"Sisi","family":"Yan","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin 150040, China"},{"name":"Key Laboratory of Basic and Application Research of Beiyao, Heilongjiang University of Chinese Medicine, Ministry of Education, Harbin 150040, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Gao","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin 150040, China"},{"name":"Key Laboratory of Basic and Application Research of Beiyao, Heilongjiang University of Chinese Medicine, Ministry of Education, Harbin 150040, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhan","family":"Fu","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin 150040, China"},{"name":"Key Laboratory of Basic and Application Research of Beiyao, Heilongjiang University of Chinese Medicine, Ministry of Education, Harbin 150040, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutong","family":"Mei","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin 150040, China"},{"name":"Key Laboratory of Basic and Application Research of Beiyao, Heilongjiang University of Chinese Medicine, Ministry of Education, Harbin 150040, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9247-1453","authenticated-orcid":false,"given":"Yanhong","family":"Wang","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin 150040, China"},{"name":"Key Laboratory of Basic and Application Research of Beiyao, Heilongjiang University of Chinese Medicine, Ministry of Education, Harbin 150040, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4514-795X","authenticated-orcid":false,"given":"Zhixin","family":"Yang","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin 150040, China"},{"name":"Key Laboratory of Basic and Application Research of Beiyao, Heilongjiang University of Chinese Medicine, Ministry of Education, Harbin 150040, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/s41420-024-02245-3","article-title":"Systemic tumor regression with synergy therapy: Radiotherapy and CAR-T","volume":"10","author":"Ma","year":"2024","journal-title":"Cell Death Discov."},{"key":"ref_2","first-page":"adtp.202300098","article-title":"Repurposing Tamoxifen for Tumor Microenvironment Priming and Enhanced Tumor-Targeted Drug Delivery","volume":"6","author":"Biancacci","year":"2023","journal-title":"Adv. Ther."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e173934","DOI":"10.1172\/JCI173934","article-title":"VHL loss reprograms the immune landscape to promote an inflammatory myeloid microenvironment in renal tumorigenesis","volume":"134","author":"Wolf","year":"2024","journal-title":"J. Clin. Investig."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"115206","DOI":"10.1016\/j.celrep.2024.115206","article-title":"Tumor-induced metabolic immunosuppression: Mechanisms and therapeutic targets","volume":"44","author":"Ricci","year":"2025","journal-title":"Cell Rep."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"6886135","DOI":"10.1155\/2023\/6886135","article-title":"Antitumor Therapy Targeting the Tumor Microenvironment","volume":"2023","author":"Gao","year":"2023","journal-title":"J. Oncol."},{"key":"ref_6","first-page":"516","article-title":"Cancer vaccine designed from homologous ferritin-based fusion protein with enhanced DC-T cell crosstalk for durable adaptive immunity against tumors","volume":"46","author":"Wu","year":"2025","journal-title":"Bioact. Mater."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/s41571-023-00848-w","article-title":"Tumour-infiltrating lymphocyte therapy for patients with advanced-stage melanoma","volume":"21","author":"Klobuch","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s12967-023-04688-1","article-title":"Potential crosstalk between SPP1 + TAMs and CD8+ exhausted T cells promotes an immunosuppressive environment in gastric metastatic cancer","volume":"22","author":"Du","year":"2024","journal-title":"J. Transl. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/s41568-024-00705-7","article-title":"Defining clinically useful biomarkers of immune checkpoint inhibitors in solid tumours","volume":"24","author":"Holder","year":"2024","journal-title":"Nat. Rev. Cancer"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"216167","DOI":"10.1016\/j.canlet.2023.216167","article-title":"Improvement strategy for immune checkpoint blockade: A focus on the combination with immunogenic cell death inducers","volume":"562","author":"Shi","year":"2023","journal-title":"Cancer Lett."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e2310456","DOI":"10.1002\/adma.202310456","article-title":"Platinum Prodrug Nanoparticles with COX-2 Inhibition Amplify Pyroptosis for Enhanced Chemotherapy and Immune Activation of Pancreatic Cancer","volume":"36","author":"Yu","year":"2024","journal-title":"Adv. Mater."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"189154","DOI":"10.1016\/j.bbcan.2024.189154","article-title":"Reactive oxygen species of tumor microenvironment: Harnessing for immunogenic cell death","volume":"1879","author":"Malla","year":"2024","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2472432","DOI":"10.1080\/15384047.2025.2472432","article-title":"The search for a TNBC vaccine: The guardian vaccine","volume":"26","author":"Fines","year":"2025","journal-title":"Cancer Biol. Ther."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"tfae108","DOI":"10.1093\/toxres\/tfae108","article-title":"Rutin mitigates acetic acid-induced ulcerative colitis: Novel coloprotective mechanism","volume":"13","author":"Sherif","year":"2024","journal-title":"Toxicol. Res."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Talib, W.H., Al Junaidi, H.S., Hadi, R.W., Ashour, T.H., Zabout, I.Z., Sabri, S.M., Alshaeri, H.K., Law, D., Hock, M., and Pr\u00e9musz, V. (2026). Targeting cancer hallmarks using resveratrol: Isolation, formulation, and mechanisms of action. Front. Nutr., 13.","DOI":"10.3389\/fnut.2026.1747820"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"56422","DOI":"10.1021\/acsami.5c11872","article-title":"Effective Delivery of Rutin Through Astragalus Polysaccharides Micelles for Downregulating PD-L1 by Inhibiting Matrix Metalloproteinases","volume":"17","author":"Li","year":"2025","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"114895","DOI":"10.1016\/j.colsurfb.2025.114895","article-title":"Construction and evaluation of pH-sensitive nanoparticles with resveratrol release to trigger the immunogenic cell death in colon cancer cells","volume":"255","author":"Li","year":"2025","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"131304","DOI":"10.1016\/j.ijbiomac.2024.131304","article-title":"Enhanced in vitro bioavailability of resveratrol-loaded emulsion stabilized by \u03b2-lactoglobulin-catechin with excellent antioxidant activity","volume":"267","author":"Wang","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s12943-023-01849-0","article-title":"Lipid polymer hybrid nanoparticles: A custom-tailored next-generation approach for cancer therapeutics","volume":"22","author":"Gajbhiye","year":"2023","journal-title":"Mol. Cancer"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e19332","DOI":"10.7717\/peerj.19332","article-title":"Research progress of nano drug delivery systems in the anti-tumor treatment of traditional Chinese medicine monomers","volume":"13","author":"Song","year":"2025","journal-title":"PeerJ"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Safta, D.A., Bogdan, C., and Moldovan, M.L. (2022). Vesicular Nanocarriers for Phytocompounds in Wound Care: Preparation and Characterization. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14050991"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"153909","DOI":"10.1016\/j.phymed.2021.153909","article-title":"Quercetin- and rutin-based nano-formulations for cancer treatment: A systematic review of improved efficacy and molecular mechanisms","volume":"97","author":"Mondal","year":"2022","journal-title":"Phytomedicine"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"107895","DOI":"10.1016\/j.intimp.2021.107895","article-title":"Resveratrol for targeting the tumor microenvironment and its interactions with cancer cells","volume":"98","author":"Mu","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s12951-022-01349-1","article-title":"Enhanced tumor accumulation and therapeutic efficacy of liposomal drugs through over-threshold dosing","volume":"20","author":"Ao","year":"2022","journal-title":"J. Nanobiotechnol."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Hern\u00e1ndez-Rangel, A.E., Hernandez-Fuentes, G.A., Montes-Galindo, D.A., Sanchez-Ramirez, C.A., Cabrera-Licona, A., Martinez-Fierro, M.L., Rodriguez-Sanchez, I.P., Garza-Veloz, I., Diaz-Martinez, J., and Casarez-Price, J.C. (2024). Vitamin D3 (Calcitriol) Monotherapy Decreases Tumor Growth, Increases Survival, and Correlates with Low Neutrophil-to-Lymphocyte Ratio in a Murine HPV-16-Related Cancer Model. Biomedicines, 12.","DOI":"10.3390\/biomedicines12061357"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1038\/s41467-026-68626-7","article-title":"G9a-mediated H3K9me2 orchestrates intestinal epithelial regeneration through epigenetic silencing of cell cycle-related genes","volume":"17","author":"Chen","year":"2026","journal-title":"Nat. Commun."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"189109","DOI":"10.1016\/j.bbcan.2024.189109","article-title":"Augmentation of the EPR effect by mild hyperthermia to improve nanoparticle delivery to the tumor","volume":"1879","author":"Aloss","year":"2024","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Moreira, T.D.S., Silva, A.D.O., Vasconcelos, B.R.F., Santos, E.D.S., de Sousa, A.C.C., de Freitas, J.V.B., de Oliveira, Y.S., Vidal, L.M.T., Ribeiro, F.O.S., and de Ara\u00fajo, A.R. (2023). DOPE\/CHEMS-Based EGFR-Targeted Immunoliposomes for Docetaxel Delivery: Formulation Development, Physicochemical Characterization and Biological Evaluation on Prostate Cancer Cells. Pharmaceutics, 15.","DOI":"10.3390\/pharmaceutics15030915"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.bpc.2017.11.003","article-title":"Protective effect of quercetin and rutin encapsulated liposomes on induced oxidative stress","volume":"233","author":"Bonechi","year":"2018","journal-title":"Biophys. Chem."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Alrbyawi, H., Poudel, I., Annaji, M., Boddu, S.H.S., Arnold, R.D., Tiwari, A.K., and Babu, R.J. (2022). pH-Sensitive Liposomes for Enhanced Cellular Uptake and Cytotoxicity of Daunorubicin in Melanoma (B16-BL6) Cell Lines. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14061128"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e2201327","DOI":"10.1002\/smtd.202201327","article-title":"Multifunctional Liposomes Remodeling Tumor Immune Microenvironment for Tumor Chemoimmunotherapy","volume":"7","author":"Li","year":"2023","journal-title":"Small Methods"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"114614","DOI":"10.1016\/j.addr.2022.114614","article-title":"The tumor EPR effect for cancer drug delivery: Current status, limitations, and alternatives","volume":"191","author":"Sun","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Mirzayans, R., and Murray, D. (2020). Do TUNEL and Other Apoptosis Assays Detect Cell Death in Preclinical Studies?. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21239090"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/s41573-024-00920-9","article-title":"Targeting immunogenic cell stress and death for cancer therapy","volume":"23","author":"Galluzzi","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.gendis.2018.05.003","article-title":"Immunogenic effects of chemotherapy-induced tumor cell death","volume":"5","author":"Wang","year":"2018","journal-title":"Genes Dis."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12943-018-0928-4","article-title":"Role of the tumor microenvironment in PD-L1\/PD-1-mediated tumor immune escape","volume":"18","author":"Jiang","year":"2019","journal-title":"Mol. Cancer"},{"key":"ref_37","first-page":"285","article-title":"NIR-II photo-accelerated polymer nanoparticles boost tumor immunotherapy via PD-L1 silencing and immunogenic cell death","volume":"46","author":"Zhang","year":"2025","journal-title":"Bioact. Mater."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"160811","DOI":"10.1016\/j.cej.2025.160811","article-title":"Epidermal growth factor receptor targeted photodynamic degrader to activate breast cancer immunity by intensifying immunogenic cell death and downregulating PD-L1","volume":"507","author":"Zhang","year":"2025","journal-title":"Chem. Eng. J."},{"key":"ref_39","first-page":"1973","article-title":"The application of nanoparticles in cancer immunotherapy: Targeting tumor microenvironment","volume":"6","author":"Yang","year":"2021","journal-title":"Bioact. Mater."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.apsb.2021.08.020","article-title":"Emerging role of natural products in cancer immunotherapy","volume":"12","author":"Dong","year":"2022","journal-title":"Acta Pharm. Sin. B"}],"container-title":["Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4923\/18\/7\/872\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T05:34:02Z","timestamp":1784266442000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4923\/18\/7\/872"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,16]]},"references-count":40,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["pharmaceutics18070872"],"URL":"https:\/\/doi.org\/10.3390\/pharmaceutics18070872","relation":{},"ISSN":["1999-4923"],"issn-type":[{"value":"1999-4923","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,16]]}}}